Shopping Cart
Remove All
Your shopping cart is currently empty
Namilumab (AMG203) is a humanised IgG1 monoclonal antibody that neutralises GM-CSF (granulocyte-macrophage colony-stimulating factor) by binding to its ligand with high affinity, and is used in the study of rheumatoid arthritis and active axial spondyloarthritis.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $247 | - | In Stock | |
| 5 mg | $747 | - | In Stock | |
| 10 mg | $1,200 | - | In Stock |
| Description | Namilumab (AMG203) is a humanised IgG1 monoclonal antibody that neutralises GM-CSF (granulocyte-macrophage colony-stimulating factor) by binding to its ligand with high affinity, and is used in the study of rheumatoid arthritis and active axial spondyloarthritis. |
| Synonyms | Anti-Human CSF2 Recombinant Antibody, AMG-203, AMG203 |
| Reactivity | Human |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | CSF2/GM-CSF |
| Molecular Weight | ~150 kDa |
| Cas No. | 1206681-39-1 |
| Color | Transparent |
| Appearance | Liquid |
| Isotype | Human IgG1 kappa |
| Recommended Isotype Control |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.